Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Aspirin Use and Risk of Glioma: a Double Track for a Single Goal?

Mormile R.

Pathol Oncol Res. 2019 Jul 22. doi: 10.1007/s12253-019-00699-w. [Epub ahead of print] No abstract available.

PMID:
31332695
2.

Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis.

Amirian ES, Ostrom QT, Armstrong GN, Lai RK, Gu X, Jacobs DI, Jalali A, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut JM, Ali-Osman F, Sadetzki S, Jenkins RB, Lachance DH, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Johansen C, Houlston RS, Scheurer ME, Shete S, Amos CI, Melin B, Bondy ML.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):555-562. doi: 10.1158/1055-9965.EPI-18-0702. Epub 2018 Nov 27.

PMID:
30482874
3.

Analgesic use and the risk of primary adult brain tumor.

Egan KM, Nabors LB, Thompson ZJ, Rozmeski CM, Anic GA, Olson JJ, LaRocca RV, Chowdhary SA, Forsyth PA, Thompson RC.

Eur J Epidemiol. 2016 Sep;31(9):917-25. doi: 10.1007/s10654-016-0129-7. Epub 2016 Feb 19.

4.

Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study.

Gaist D, García-Rodríguez LA, Sørensen HT, Hallas J, Friis S.

Br J Cancer. 2013 Mar 19;108(5):1189-94. doi: 10.1038/bjc.2013.87. Epub 2013 Feb 28.

5.

Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.

Ming J, Sun B, Li Z, Lin L, Meng X, Han B, Wang R, Wu P, Li J, Cai J, Jiang C.

Aging (Albany NY). 2017 Apr;9(4):1233-1247. doi: 10.18632/aging.101224.

6.

Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink.

Bannon FJ, O'Rorke MA, Murray LJ, Hughes CM, Gavin AT, Fleming SJ, Cardwell CR.

Cancer Causes Control. 2013 Nov;24(11):2027-34. doi: 10.1007/s10552-013-0279-9. Epub 2013 Aug 30.

PMID:
23990380
7.

Overexpression of S100A9 in human glioma and in-vitro inhibition by aspirin.

Huang N, Chen S, Deng J, Huang Q, Liao P, Wang F, Cheng Y.

Eur J Cancer Prev. 2013 Nov;22(6):585-95. doi: 10.1097/CEJ.0b013e328364f1c9.

PMID:
24064546
8.

Effect of aspirin and indomethacin on prostaglandin E2 synthesis in C6 glioma cells.

Hwang SL, Lee KS, Lin CL, Lieu AS, Cheng CY, Loh JK, Hwang YF, Su YF, Howng SL.

Kaohsiung J Med Sci. 2004 Jan;20(1):1-5.

9.

Cyclooxygenase inhibitor induces the upregulation of connexin-43 expression in C6 glioma cells.

Qin LJ, Jia YS, Zhang YB, Wang YH.

Biomed Rep. 2016 Apr;4(4):444-448. Epub 2016 Feb 25.

10.

Antitumor effect of aspirin in glioblastoma cells by modulation of β-catenin/T-cell factor-mediated transcriptional activity.

Lan F, Yue X, Han L, Yuan X, Shi Z, Huang K, Yang Y, Zou J, Zhang J, Jiang T, Pu P, Kang C.

J Neurosurg. 2011 Oct;115(4):780-8. doi: 10.3171/2011.5.JNS113. Epub 2011 Jul 1.

PMID:
21721879
12.

β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.

Chen L, Huang K, Han L, Shi Z, Zhang K, Pu P, Jiang C, Kang C.

Int J Oncol. 2011 Oct;39(4):883-90. doi: 10.3892/ijo.2011.1104. Epub 2011 Jun 29.

PMID:
21720709
13.

Thromboembolism in patients with high-grade glioma.

Quevedo JF, Buckner JC, Schmidt JL, Dinapoli RP, O'Fallon JR.

Mayo Clin Proc. 1994 Apr;69(4):329-32.

PMID:
8170176
14.

Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility.

Zhao P, Zou P, Zhao L, Yan W, Kang C, Jiang T, You Y.

BMC Cancer. 2013 May 10;13:234. doi: 10.1186/1471-2407-13-234.

16.

Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.

Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO.

Cancer J Sci Am. 1998 Nov-Dec;4(6):364-9.

PMID:
9853135
18.

Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort.

Daugherty SE, Moore SC, Pfeiffer RM, Inskip PD, Park Y, Hollenbeck A, Rajaraman P.

Cancer Prev Res (Phila). 2011 Dec;4(12):2027-34. doi: 10.1158/1940-6207.CAPR-11-0274. Epub 2011 Sep 1.

19.

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators.

Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4.

PMID:
20817281
20.

Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.

Kojuri J, Mahmoody Y, Zangbar Sabegh B, Jannati M, Mahboodi A, Khalili A.

Cardiovasc Ther. 2010 Jun;28(3):147-52. doi: 10.1111/j.1755-5922.2010.00170.x.

PMID:
20557313

Supplemental Content

Support Center